Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


Point of Care Diagnostics - Economic Reimbursement & Technology Trends

24 Oct 2012 - 25 Oct 2012 - London, UK



Bookmark and Share


SMi present their 9th annual Point of Care Diagnostics conference, which will bring together key members of the diagnostics and healthcare industries to discuss the implementation of technology, the reimbursements of the industry, and the connectivity of point of care technology throughout Europe and the world.

Benefits of Attending:

· Network with diagnostic manufacturers, pharmaceutical specialists and key healthcare practitioners working with POC technology

· Explore the economics, market developments, connectivity and the controversial topics of the POC industry

· Learn about the current market pulls and emerging technologies, and the ways they affect the medical diagnostics industry

· Discuss the POC industry, its potential expansion into wider markets and its future in the NHS and in European healthcare

· Consider new emerging technologies, and speak to the industry leaders at the forefront of development, manufacture and usage

Keynote Speakers include:

· Thomas Li, Senior Director, Technology Management, Roche Diagnostics, Singapore 

· Hans Winkler, Senior Director, Biomarkers, Janssen R&D (a Johnson & Johnson company) 

· David Huckle, President & Director General, ABA – France 

· Gilbert Greub, Chief of Medicine, Institute of Microbiology 

· Christopher Lowe, Director of the Institute of Biotechnology, University of Cambridge 

PLUS 2 INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS 

Tuesday 23rd of October, 2012, Copthorne Tara Hotel, London

A: Health economics, reimbursement, and market access for POC technologies

Workshop Leader: Kuo Tong, President & Founder, Quorum Consulting

8:30 – 12:30

B: The Future of Healthcare: Connecting the vision

Workshop leader: Simon Burnell, Partner, PA Consulting

13:30 – 17:30 pm

***Book before 31st May 2012 and save £300***

***Book before 29th June 2012 and save £100***

Visit our website here: http://www.smi-online.co.uk/goto/2012pointofcare8.asp

Alternatively Contact Shilan Chandi on tel: +44 (0) 20 7827 6738 or email: schandi@smi-online.co.uk



Further information
Scientific News
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Angina Drug Could Inform A New Strategy To Fight Cryptococcosis
A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!